Spinocerebellar Ataxia Type 1 (SCA1) is a genetic condition caused by a dominant allele.
Explain what is meant by the term dominant allele.
The symptoms of SCA1 usually appear in middle age, with progressive coordination and balance problems. There is currently no cure.
Scientists have established that the severity and age of onset of SCA1 are related to the number of CAG trinucleotide repeats in the ATXN1 gene.
People can undergo a genetic test to find out if they carry the mutated allele and the exact number of CAG repeats they have.
The graph below shows the relationship between the number of CAG repeats and the age at which symptoms first develop.

Discuss how useful the genetic test and the graph are for a person whose parent has been diagnosed with SCA1.
A potential therapeutic approach involves using synthetic antisense oligonucleotides (ASOs) that bind specifically to the mRNA transcribed from the mutant ATXN1 gene, preventing its translation.
Explain how this drug could prevent or delay the onset of SCA1 symptoms.